Estimates of the time from seroconversion to ART initiation among people newly diagnosed with HIV from 2006 to 2015, New York City.
We estimated the time from HIV seroconversion to ART initiation in a population-based sample of people diagnosed with HIV during an era of expanding HIV testing and treatment efforts. Applying CD4 depletion model parameters from seroconverter cohort data to our population-based sample, we related the square root of the first pre-treatment CD4 count to time of serconversion though a linear mixed model and estimated the time from seroconversion to diagnosis and ART initiation. Among 28,162 people diagnosed with HIV during 2006-2015, 89% initiated ART by June 2017. The median CD4 count at diagnosis increased from 326 (Interquartile range (IQR):132-504) to 390 (IQR:216-571) cells/µL from 2006-2015. The median time from estimated seroconversion to ART initiation decreased by 42% from 6.4 years (IQR:3.3-11.4) in 2006 to 3.7 years (IQR:0.5-8.3) in 2015. Contributing to the reduction in time to ART initiation, the time from estimated seroconversion to diagnosis decreased by 28%, from a median of 4.6 years (IQR:0.5-10.5) to 3.3 years (IQR:0-8.1) from 2006-2015, and the time from diagnosis to ART initiation reduced by 60%, from a median of 0.5 years (IQR:0.2-2.1) to 0.2 years (IQR:0.1-0.3) from 2006-2015. The estimated time from seroconversion to ART initiation was reduced in tandem with expanded HIV testing and treatment efforts. While the time from diagnosis to ART initiation decreased to a median of 0.2 years, the time from seroconversion to diagnosis was 3.3 years among people diagnosed in 2015, highlighting the need for more effective strategies for earlier HIV diagnosis.